A Phase 2, Randomized, Double-blind, Placebo-Controlled Efficacy, Pharmacokinetics and Safety Study of CA-008 in Subjects Undergoing Total Knee Arthroplasty
Phase of Trial: Phase II
Latest Information Update: 04 Feb 2019
At a glance
- Drugs CA-008 (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Concentric Analgesics
- 24 Jan 2019 Planned number of patients changed from 66 to 200.
- 12 Nov 2018 New trial record
- 07 Nov 2018 Status changed from not yet recruiting to recruiting.